- Report
- April 2025
- 200 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- February 2026
- 381 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 214 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 375 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 303 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- February 2026
- 486 Pages
Global
From €5084EUR$5,850USD£4,425GBP
- Report
- October 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- September 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- September 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- February 2025
- 200 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- January 2026
- 195 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- August 2025
- 187 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- August 2025
- 199 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- October 2025
- 183 Pages
Global
From €3423EUR$3,939USD£2,979GBP
- Report
- May 2025
- 188 Pages
Global
From €3911EUR$4,500USD£3,404GBP
- Report
- February 2025
- 182 Pages
Global
From €3911EUR$4,500USD£3,404GBP
- Report
- September 2025
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- February 2025
- 188 Pages
Global
From €3911EUR$4,500USD£3,404GBP
- Report
- January 2026
- 250 Pages
Global
From €3902EUR$4,490USD£3,396GBP
- Report
- January 2026
- 185 Pages
Global
From €3911EUR$4,500USD£3,404GBP

The Drug Discovery AI market is a rapidly growing sector of the pharmaceutical industry, focused on the development of artificial intelligence (AI) technologies to aid in the discovery of new drugs. AI-driven drug discovery is a process that uses machine learning algorithms to identify potential drug targets and develop new drug candidates. AI-driven drug discovery can reduce the time and cost of drug development, as well as improve the accuracy of drug discovery.
The Drug Discovery AI market is composed of a variety of companies, ranging from large pharmaceutical companies to small startups. Companies in the market include Atomwise, Exscientia, Insilico Medicine, and Recursion Pharmaceuticals. These companies are developing AI-driven drug discovery technologies to help accelerate the drug discovery process. Show Less Read more